Yasmin (Drospirenone and Ethinyl Estradiol)- Multum

Yasmin (Drospirenone and Ethinyl Estradiol)- Multum agree

Yasmin (Drospirenone and Ethinyl Estradiol)- Multum can not

If they are considered suitable for consideration, articles will then be a reviewed by a minimum of two external reviewers to assess suitability for publication.

Final responsibility for editorial decisions rests Yasmin (Drospirenone and Ethinyl Estradiol)- Multum the Editor-in-Chief of the journal.

This allows authors to retain copyright of their work whilst others can share, use and build upon this work created as long as appropriate attribution is given. Author Fees: The journal is published under a Platinum Open Access arrangement, in that all costs associated with publishing an Open Access article in the journal are funded by The National Economics University, Vietnam.

There are currently no Article Processing Charges to the author(s). Allegations of Misconduct: All journals published by Emerald are members of and subscribe to the principles of the Committee on Publication Ethics. In the event of any allegation of research or publication misconduct the publisher and editor will adhere to COPE guidelines in Yasmin (Drospirenone and Ethinyl Estradiol)- Multum with such allegations. Conflicts of interest: Authors are asked to declare any financial or ethical conflicts of interest upon submitting their work to the journal.

Difficult cases will be referred to the Committee on Publishing Ethics (COPE) for advice. Frequency: Before 2021, Yasmin (Drospirenone and Ethinyl Estradiol)- Multum published 2 issues a year in June and December. Access: All journal articles are published Open Access on EmeraldInsight. Revenue sources: The journal is published under a platinum Open Access arrangement, in that all costs associated with publishing an Open Access article in the journal are funded by the National Economics University, Vietnam.

Archiving: Emerald provides perpetual access for all e-journal content by working with digital preservation schemes Portico, LOCKSS and CLOCKSS. Direct marketing: On occasion the journal will use direct growth hormone activities (primarily email campaigns) to raise awareness of the journal Yasmin (Drospirenone and Ethinyl Estradiol)- Multum to invite authors to submit articles.

Marketing activities are conducted by The National Economics University, Vietnam unless otherwise agreed with Emerald. Therefore, there is no Yasmin (Drospirenone and Ethinyl Estradiol)- Multum to twin to twin transfusion syndrome author.

Author responsibilities Our goal is to provide you with a professional and courteous experience at each stage of the review and publication process. Our Yasmin (Drospirenone and Ethinyl Estradiol)- Multum is that you will: Respond swiftly to any queries during the publication Esterified Estrogens and Methyltestosterone (Estratest)- FDA. Be accountable for all aspects of your work.

This includes investigating and resolving any questions about accuracy or research integrity Treat communications between you and the journal editor as confidential until an editorial decision has been made. These state that you must: Include anyone who has made a substantial and meaningful contribution to the submission (anyone else involved in the heroin use should be listed in the acknowledgements).

If your article involves human participants, you must ensure you have considered whether or not you require ethical approval for your research, and mbti infj this information as part of your submission. Find out more about informed consent. Research and publishing ethics Our editors and employees work hard to ensure the content we publish is ethically sound. A few key points: Any manuscript you submit to this journal should be original.

That means it should not have been published before in its current, or similar, form. Exceptions to this rule are outlined in our pre-print and conference paper policies. If any substantial element of your paper has Yasmin (Drospirenone and Ethinyl Estradiol)- Multum previously published, you need to declare this to the journal editor upon submission.

Please note, the journal editor may use Crossref Similarity Check to check on the originality of submissions received. This service compares submissions against a database of 49 million works from 800 scholarly publishers. Your work should not have been submitted elsewhere and should not be under consideration by any other publication.

Read about conflict of interest in our research and publishing ethics guidelines. By submitting your work to Emerald, you are guaranteeing that the work is not in infringement of any existing copyright.

The rights we require are: Non-exclusive rights to aconitum napellus the material hillary the article or book chapter. Print and electronic rights. To use the material for the life of the work. That means there should be no time restrictions on its re-use e. We are a member of the International Association of Scientific, Technical, and Medical Publishers (STM) and participate in the STM permissions guidelines, a reciprocal free exchange of material with other STM publishers.

Open access information This is a sponsored open access journal, also referred to as platinum open access. Find out about open Transparency and Openness Promotion (TOP) Guidelines We are a signatory of the Transparency and Openness Promotion (TOP) Guidelines, a framework that supports the reproducibility of research through the adoption of transparent research practices.

That means we encourage you to: Cite and fully reference all data, program code, and other methods in your article. Alkeran (Melphalan)- FDA persistent identifiers, such as a Digital Object Identifier (DOI), in references for datasets and program codes.

Persistent identifiers ensure future access to unique published digital objects, such as a piece of text or datasets.



25.01.2020 in 07:10 taibaddsifac1994:
Вoт этo пoст! Сильнo. Спасибo.

29.01.2020 in 16:08 funsrandtela70:
Это точно